tiprankstipranks
Tenet Healthcare (THC)
NYSE:THC
US Market
Holding THC?
Track your performance easily

Tenet Healthcare (THC) Earnings Dates, Call Summary & Reports

829 Followers

Earnings Data

Report Date
Feb 12, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
2.95
Last Year’s EPS
2.68
Same Quarter Last Year
Based on 15 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 05, 2018
|
% Change Since: -6.19%
|
Next Earnings Date:Aug 06, 2018
Earnings Call Sentiment|Positive
The earnings call reflected a strong financial performance and positive growth across key segments, leading to increased guidance for 2024. Despite challenges such as hurricane impacts and managed care issues, the company demonstrated effective cost management and strategic portfolio adjustments. The overall sentiment is optimistic, with ongoing efforts to enhance shareholder value through strategic investments and deleveraging.
Company Guidance
During the Tenet Healthcare Q3 2024 earnings call, the company provided a robust financial outlook, raising its full-year adjusted EBITDA guidance to a range of $3.9 billion to $4 billion, an increase of $50 million from prior guidance. This revision highlights strong performance across business units, including a reported 15% year-over-year growth in consolidated adjusted EBITDA to $978 million for the quarter, with a margin of 19.1%. The USPI segment showed impressive results, boasting $439 million in adjusted EBITDA, marking a 19% increase over the previous year. Hospital segment adjusted EBITDA also grew by 11%, totaling $539 million, with same-store hospital admissions rising by 5.2%. The company's strategic focus on high-acuity service lines and efficient operations has contributed to this success, alongside strategic divestitures that have enhanced the hospital portfolio's return profile. Tenet also highlighted its commitment to capital deployment for growth, including investments in its ambulatory surgical business and potential share repurchases.
Strong Financial Performance
Tenet Healthcare reported net operating revenues of $5.1 billion for Q3 2024. Consolidated adjusted EBITDA was $978 million, showing a 15% increase over Q3 2023, with an adjusted EBITDA margin of 19.1%.
USPI Segment Growth
The USPI segment reported $439 million in adjusted EBITDA, representing a 19% growth over Q3 2023. Same-facility revenues increased by 8.7%.
Hospital Segment Progress
Hospital segment adjusted EBITDA was $539 million, indicating an 11% growth over Q3 2023. Same-store hospital admissions increased by 5.2%, with revenue per adjusted admission up 3.3%.
Increased 2024 Guidance
Tenet raised its full-year 2024 adjusted EBITDA guidance to a range of $3.9 billion to $4 billion, an increase of $50 million at the midpoint over prior guidance.
Portfolio Transformation
Completed the sale of Alabama hospitals, enhancing the return profile of the current hospital portfolio. Conifer has retained and, in many cases, expanded relationships with acquirers.
Deleveraging Success
Tenet reported a leverage ratio of around 3 on an EBITDA minus NCI basis, demonstrating significant deleveraging accomplishments.
---

Tenet Healthcare (THC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

THC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 06, 20182018 (Q2)
- / 0.49
-0.17388.24% (+0.66)
Nov 05, 20182018 (Q3)
- / 0.29
-0.17270.59% (+0.46)
Feb 25, 20192018 (Q4)
- / 0.51
1.4-63.57% (-0.89)
Apr 29, 20192019 (Q1)
- / 0.54
0.57-5.26% (-0.03)
Aug 05, 20192019 (Q2)
- / 0.56
0.4914.29% (+0.07)
Nov 04, 20192019 (Q3)
- / 0.58
0.29100.00% (+0.29)
Feb 24, 20202019 (Q4)
- / 0.99
0.5194.12% (+0.48)
May 04, 20202020 (Q1)
- / 1.28
0.54137.04% (+0.74)
Aug 03, 20202020 (Q2)
- / 1.26
0.56125.00% (+0.70)
Oct 20, 20202020 (Q3)
- / 0.64
0.5810.34% (+0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

THC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 29, 2024$139.49$162.76+16.68%
Jul 24, 2024$138.68$145.34+4.80%
Apr 30, 2024$99.15$112.29+13.25%
Feb 08, 2024$88.11$89.02+1.03%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Tenet Healthcare (THC) report earnings?
Tenet Healthcare (THC) is schdueled to report earning on Feb 12, 2025, TBA Not Confirmed.
    What is Tenet Healthcare (THC) earnings time?
    Tenet Healthcare (THC) earnings time is at Feb 12, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is THC EPS forecast?
          THC EPS forecast for the fiscal quarter 2024 (Q4) is 2.95.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis